Soros Fund Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Soros Fund Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-236,700	Closed	-$25.2M	–	284
2016 Q2	$25.2M	Buy	236,700 +87,000	+58%	+$10.1M	0.54%	35
2016 Q1	$17.1M	Buy	149,700 +82,000	+121%	+$9.62M	0.38%	59
2015 Q4	$9.64M	Buy	+67,700	New	+$7.81M	0.16%	103

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Soros Fund Management's CBPO Position: Q3 2016 in Review

Soros Fund Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2016, closing a stake of 236,700 shares — an estimated $25.2M sold.

Soros Fund Management first reported a position in CBPO in Q4 2015 and held it in 3 quarters. The position peaked at $25.2M in Q2 2016. 162 funds tracked by Wall St. Rank hold CBPO as of Q3 2016.

Soros Fund Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
Soros Fund Management sold 236,700 China Biologic Products Holdings, Inc. shares in Q3 2016, an estimated $25.2M.
Soros Fund Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 3 quarters.
Soros Fund Management's China Biologic Products Holdings, Inc. position peaked at $25.2M in Q2 2016.
162 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2016.

Based on Soros Fund Management's 13F filing for Q3 2016, filed 14 Nov 2016.